8 July 2020
Latham & Watkins Advises Initial Purchasers in Pacira BioSciences Inc.’s Upsized US$350 Million Convertible Senior Notes Offering
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Greg Rodgers Lead | Latham & Watkins LLP | Partner | corporate | New York |
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | corporate | New York |
| Arash Aminian Baghai | Latham & Watkins LLP | Counsel | corporate | New York |
| Taylor Stevens | Latham & Watkins LLP | Associate | corporate | New York |
| Ryan Gold | Latham & Watkins LLP | Associate | corporate | New York |
| Regan Devers | Latham & Watkins LLP | Associate | corporate | New York |
| Reza Mojtabaee-Zamani | Latham & Watkins LLP | Partner | equity derivative matters | New York |
| Eric Rice | Latham & Watkins LLP | Associate | equity derivative matters | New York |
| Dian Yu | Latham & Watkins LLP | Associate | equity derivative matters | New York |
| Elena Romanova | Latham & Watkins LLP | Partner | tax matters | New York |
| Lea Li | Latham & Watkins LLP | Associate | tax matters | New York |
| Ron Moore | Latham & Watkins LLP | Associate | tax matters | New York |
Stated terms
- Stated value
- USD 350m (US$350 million)
- What the figure measures
- Issue size
- Client
- Initial PurchasersUnderwriters
- Counterparties
- Pacira BioSciences, Inc. (Issuer)